Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Amarin Corp ADR (NQ: AMRN )

0.8661 -0.0139 (-1.58%)
Streaming Delayed Price Updated: 11:22 AM EDT, Apr 24, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Amarin Corp ADR

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
The Daily Biotech Pulse: Legend Biotech, CTI Biopharma Receive FDA Approvals, AbbVie Announces Delay In Skyrizi Review, Editas Gains On CRISPR Patent Resolution
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Editas Gains On Resolution Of CRISPR Gene Editing Patent Case Editas Medicine... 
Via Benzinga
Lower Vascepa Volume Hits Amarin's Q4 Topline Growth
Amarin Corp plc's (NASDAQ: AMRN) Q4 FY21 sales decreased 13.6% Y/Y to $144.49 million, beating the consensus of $141.75 million. The decline was driven primarily by... 
Via Benzinga
Amarin: Q4 Earnings Insights
Amarin Corp (NASDAQ:AMRN) reported its Q4 earnings results on Tuesday, March 1, 2022 at 06:00 AM. Here's what investors need to know about the announcement. Earnings... 
Via Benzinga
Earnings Scheduled For March 1, 2022
Companies Reporting Before The Bell • Precigen (NASDAQ:PGEN) is expected to report earnings for its fourth quarter. • TG Therapeutics (NASDAQ:TGTX) is estimated... 
Via Benzinga
The Week Ahead In Biotech (Feb. 27-March 5): Earnings, Multiple Regulatory Decisions Take The Spotlight
Biopharma stocks lock-stepped with the broader market in the week ending Feb. 25 before finishing higher. The trajectory was the same, with the sector declining in the first... 
Via Benzinga
51 Biggest Movers From Yesterday
Gainers Sierra Oncology, Inc. (NASDAQ: SRRA) shares climbed 46.2% to close at $22.68 on Tuesday after the company unveiled topline data for momelotinib in myelofibrosis patients... 
Via Benzinga
28 Stocks Moving In Tuesday's Mid-Day Session
Gainers Sierra Oncology, Inc. (NASDAQ: SRRA) shares jumped 47.8% to $22.93 after the company unveiled topline data for momelotinib in myelofibrosis patients who are symptomatic,... 
Via Benzinga
The Daily Biotech Pulse: Pfizer-BioNTech Starts Omicron-Specific Vaccine Study, J&J Misses On Topline, Sierra Oncology Reports Positive Data
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Pfizer, BioNTech Initiates Study Of Omicron-Based Vaccine Candidate Pfizer,... 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
Good morning, investor! We're starting off the day right with a dive into the biggest pre-market stock movers for Tuesday! 
Via InvestorPlace
NASDAQ: AMRN Investor Notice: Deadline on December 23, 2021in Lawsuit Against Amarin Corporation Plc
San Diego, CA -- (SBWIRE) -- 12/16/2021 -- A Deadline is coming up on December 23, 2021 in the lawsuit for certain investors in Amarin Corporation plc (NASDAQ: AMRN). 
Via SBWire
Why Amarin Stock Tumbled in November
The biopharma's stock could be near a bottom after last month's double-digit decline. 
Via The Motley Fool
SHAREHOLDER ACTION NOTICE: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Amarin Corporation, plc and Encourages Investors with Losses in Excess of $500,000 to Contact the Firm
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Intellectual Property Lawsuit
Exposures Financial Intellectual Property Legal
LAWSUITS FILED AGAINST AMRN, CEI and SBTX - JAKUBOWITZ LAW PURSUES SHAREHOLDERS CLAIMS
NEW YORK, NY / ACCESSWIRE / November 22, 2021 / Jakubowitz Law announces that securities fraud class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies... 
From Jakubowitz Law
Via AccessWire
Topics Fraud Intellectual Property Lawsuit
Exposures Financial Intellectual Property Legal
The Gross Law Firm Announces Class Actions on Behalf of Shareholders of HEPS, AMRN and FB
NEW YORK, NY / ACCESSWIRE / November 19, 2021 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly traded... 
From The Gross Law Firm
Via AccessWire
Topics Intellectual Property Lawsuit
Exposures Financial Intellectual Property Legal
CLASS ACTION UPDATE for BMRN, AMRN and Z: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
NEW YORK, NY / ACCESSWIRE / November 19, 2021 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies.... 
From Levi & Korsinsky, LLP
Via AccessWire
Topics Intellectual Property Lawsuit
Exposures Financial Intellectual Property Legal
Lawsuits Filed Against AMRN, RECAF and HMLP - Jakubowitz Law Pursues Shareholders Claims
NEW YORK, NY / ACCESSWIRE / November 18, 2021 / Jakubowitz Law announces that securities fraud class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies... 
From Jakubowitz Law
Via AccessWire
Topics Fraud Intellectual Property Lawsuit
Exposures COVID-19 Financial Intellectual Property
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of AMRN, FB and NVAX
NEW YORK, NY / ACCESSWIRE / November 18, 2021 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to... 
From The Klein Law Firm
Via AccessWire
Topics Fraud Intellectual Property Lawsuit
Exposures Financial Intellectual Property Legal
CLASS ACTION UPDATE for INNV, ZEV and AMRN: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
NEW YORK, NY / ACCESSWIRE / November 18, 2021 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies.... 
From Levi & Korsinsky, LLP
Via AccessWire
Topics Intellectual Property Lawsuit
Exposures Financial Intellectual Property Legal
SHAREHOLDER ALERT: AMRN CEI SNAP: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
NEW YORK, NY / ACCESSWIRE / November 17, 2021 / The Law Offices of Vincent Wong announce that class actions have commenced on behalf of certain shareholders in the following companies. If you suffered... 
From The Law Offices of Vincent Wong
Via AccessWire
Topics Fraud Intellectual Property
Exposures Intellectual Property Legal
The Gross Law Firm Announces Class Actions on Behalf of Shareholders of AMRN, HMLP and ONTF
NEW YORK, NY / ACCESSWIRE / November 17, 2021 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly traded... 
From The Gross Law Firm
Via AccessWire
Topics Initial Public Offering Intellectual Property Lawsuit
Exposures COVID-19 Financial Intellectual Property
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of AMRN, RECAF and CEI
NEW YORK, NY / ACCESSWIRE / November 16, 2021 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to... 
From The Klein Law Firm
Via AccessWire
Topics Fraud Intellectual Property Lawsuit
Exposures Financial Intellectual Property Legal
Why Amarin Stock Crushed the Market on Tuesday
An activist investor revealed that it held a small stake in the company. 
Via The Motley Fool
Amarin Posts Encouraging Vascepa Data In Patients With Peripheral Artery Disease
Amarin Corporation plc (NASDAQ: AMRN) reported new data for Vascepa/Vazkepa (icosapent ethyl) at the American Heart Association (AHA) Scientific Sessions. The... 
Via Benzinga
The Daily Biotech Pulse: Kezar Jumps On Data, Biogen R&D Chief To Retire, Molecular Partners Wilts On COVID Trial Disappointment
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Kezar Life Sciences Reports Positive Interim Phase 2 Data For Lupus Nephritis... 
Via Benzinga
SHAREHOLDER ALERT: AMRN ONTF NVAX: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
NEW YORK, NY / ACCESSWIRE / November 16, 2021 / The Law Offices of Vincent Wong announce that class actions have commenced on behalf of certain shareholders in the following companies. If you suffered... 
From The Law Offices of Vincent Wong
Via AccessWire
Topics Fraud Initial Public Offering Intellectual Property
Exposures COVID-19 Financial Intellectual Property
SHAREHOLDER ALERT: BMRN AMRN SNAP: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
NEW YORK, NY / ACCESSWIRE / November 15, 2021 / The Law Offices of Vincent Wong announce that class actions have commenced on behalf of certain shareholders in the following companies. If you suffered... 
From The Law Offices of Vincent Wong
Via AccessWire
Topics Fraud Intellectual Property
Exposures Intellectual Property Legal
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of AMRN, RECAF and SNAP
NEW YORK, NY / ACCESSWIRE / November 13, 2021 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to... 
From The Klein Law Firm
Via AccessWire
Topics Fraud Intellectual Property Lawsuit
Exposures Financial Intellectual Property Legal
The Week Ahead In Biotech (Nov. 14-Nov. 20): BioMarin FDA Decision, Tapering Earnings News Flow, Conference Presentations And More
Biotech stocks declined for the second straight week amid a broader market pullback, along with earnings news from small- and micro-cap companies and presentations at... 
Via Benzinga
Exposures Product Safety
CLASS ACTION UPDATE for HNST, AMRN and HMLP: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
NEW YORK, NY / ACCESSWIRE / November 12, 2021 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies.... 
From Levi & Korsinsky, LLP
Via AccessWire
Topics Initial Public Offering Intellectual Property Lawsuit
Exposures COVID-19 Financial Intellectual Property
CLASS ACTION UPDATE for NNOX, AMRN and RECAF: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
NEW YORK, NY / ACCESSWIRE / November 10, 2021 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies.... 
From Levi & Korsinsky, LLP
Via AccessWire
Topics Intellectual Property Lawsuit
Exposures Financial Intellectual Property Legal
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.